Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
66.5M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
299K
-
Shares change
-
+299K
-
Total reported value, excl. options
-
$153K
-
Value change
-
+$153K
-
Number of buys
-
6
-
Price
-
$0.51
Significant Holders of INOVIO PHARMACEUTICALS, INC. - COMMON STOCK (INO) as of Q4 2023
7 filings reported holding INO - INOVIO PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2023.
INOVIO PHARMACEUTICALS, INC. - COMMON STOCK (INO) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 299K shares
of 66.5M outstanding shares and own 0.45% of the company stock.
Largest 7 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (150K shares), TUDOR INVESTMENT CORP ET AL (135K shares), Farther Finance Advisors, LLC (10.5K shares), EverSource Wealth Advisors, LLC (2.31K shares), Cornerstone Planning Group LLC (900 shares), Advisory Services Network, LLC (400 shares), and Financial Gravity Asset Management, Inc. (17 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.